US Patent Issued to Genetic Analysis AS on April 7 for "Companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant" (Norwegian Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,596,121, issued on April 7, was assigned to Genetic Analysis AS (Oslo, Norway).

"Companion diagnostic method for use in the treatment of irritable bowel syndrome with dietary interventions or faecal microbiota transplant" was invented by Finn Terje Hegge (Oslo, Norway), Christina Casen (Oslo, Norway), Jorgen Valeur (Oslo, Norway), Arne Roseth (Oslo, Norway) and Milada Cvancarova Smastuen (Oslo, Norway).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a diagnostic method which may be used to determine the likelihood that a subject with Irritable Bowel Syndrome (IBS) will respond to treatment with an IBS intervention diet. In p...